bio:cap in Berlin: New investment event for life sciences and AI!

bio:cap in Berlin: New investment event for life sciences and AI!

There is exciting news in the German capital that could significantly shape the future of the healthcare and biotech industry. The premiere of a new event format called bio:cap is planned for June 2nd and 3rd, 2026, which is initiated by the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health in the Charité (BIH). This new type of trade fair aims to connect international investors directly with innovative start-ups, research institutions and companies from the fields of biotechnology, TechBio and artificial intelligence. According to Charité, the bio:cap is intended to attract investment and promote professional exchange.

The organizers, which also include Messe Berlin, are actively supported by partners such as the Investitionsbank Berlin (IBB) and the Investitionsbank des Landes Brandenburg (ILB). bio:cap is viewed as an addition to Messe Berlin's event portfolio and aims to establish itself as a leading life science and AI event in Europe.

Innovation and networking in focus

What exactly can visitors and exhibitors expect from bio:cap? The event promises high-quality content and strategic matchmaking. This includes start-up presentations, research topics and political discussions that address current challenges in the industry. A particular focus will be on the role of artificial intelligence in the life sciences. The organizers are relying on an open, interactive format that aims to offer both stage presentations and retreats for personal discussions between investors and start-ups.

Berlin itself has established itself as a true start-up capital. With a combination of entrepreneurial spirit and creative culture, the city attracts talent, capital and creative minds from around the world. Together with Brandenburg, Berlin has formed an impressive science cluster that produces innovations in biotechnology, AI and digital health. Messe Berlin notes that in this inspiring setting, state-of-the-art tech hubs and a lively nightlife merge, promoting openness and exchange.

Funding opportunities and support

But the bio:cap will not only provide a breath of fresh air on stage. The event also serves as a catalyst for investment in the life sciences. Here, framework conditions are created for investors and founders and political strategies for science and growth are discussed. The networking of politics with actors from science, investments and pharmaceuticals is a central component of bio:cap. The event is also seen as a political signal for positioning European innovative strength.

bio:cap also offers a platform for data-driven biomedicine and interdisciplinary partnerships. Similar initiatives in the industry, such as the support of BIOPRO Baden-Württemberg, show how important it is to support founders in the areas of biotechnology, medical technology and pharmaceuticals. Whether before the founding or in the first few years after the start - support from experienced coaches and the provision of contacts to the industry are crucial for success.

bio:cap promises to be an exciting event for everyone involved and could lay the foundation for numerous innovative projects. Berlin has established itself as a catalyst for these developments and we can look forward to seeing what new opportunities this event will open up.